For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Dabigatran etexilate - VTE treatment and prevention (children)
PAD Profile : Dabigatran etexilate - VTE treatment and prevention (children)
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
- Atrial fibrillation
- VTE prevention post hip/knee replacement
- Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE)
Additional Documents
No additional documents returned.
Committee Recommendations
This drug has not yet been assessed for formulary status and is not currently on the APC work-plan.
This drug has not yet been evaluated by the Surrey Heartlands Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this drug.
The APC will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsicb.APC@nhs.net if they wish to make a submission.